Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

21st Jul 2022 17:30

RNS Number : 3599T
Haleon PLC
21 July 2022
 

HALEON PLC 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

21 July 2022 

 

Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them. 

 

On 21 July 2022, Haleon plc (the "Company") received notification of the following transactions as detailed below

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Tobias Hestler 

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Financial Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

 

Nature of the transaction

 

 

Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.

 

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

1,033 

d)

 

Aggregated information

- Aggregated volume 

1,033 

- Price 

n/a 

e)

 

Date of the transaction

 

18 July 2022 

f)

 

Place of the transaction

 

London Stock Exchange 

 

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

 

Amy Landucci 

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

 

Haleon plc 

b)

 

LEI

 

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

 

Nature of the transaction

 

 

Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

379

d)

 

Aggregated information

- Aggregated volume 

379 

- Price 

n/a 

e)

 

Date of the transaction

 

 

18 July 2022 

f)

 

Place of the transaction

 

 

London Stock Exchange 

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Bart Derde 

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Supply Chain Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

 

Nature of the transaction

 

 

Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.

 

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

837

d)

 

Aggregated information

- Aggregated volume 

837 

- Price 

n/a 

e)

 

Date of the transaction

 

18 July 2022 

f)

 

Place of the transaction

 

London Stock Exchange 

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

 

Jooyong Lee 

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Head of Strategy and Office of the CEO - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

 

Nature of the transaction

 

 

Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

386 

d)

 

Aggregated information

- Aggregated volume 

386 

- Price 

n/a 

e)

 

Date of the transaction

 

 

18 July 2022 

f)

 

Place of the transaction

 

London Stock Exchange 

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Tamara Rogers 

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Marketing Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

 

Nature of the transaction

 

 

Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.

 

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

937 

d)

 

Aggregated information

- Aggregated volume 

937 

- Price 

n/a 

e)

 

Date of the transaction

 

18 July 2022 

f)

 

Place of the transaction

 

London Stock Exchange 

 

 

Amanda Mellor 

Company Secretary 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDRUGDDGDB

Related Shares:

Haleon
FTSE 100 Latest
Value8,632.33
Change89.77